IJCM_280A: A prospective study on safety and clinical efficacy of rabies biologicals in paediatric patients with category III animal exposure
Background: Rabies remains a significant public health concern worldwide, particularly among paediatric populations who are vulnerable to animal exposures. This prospective study aimed to assess the safety and clinical efficacy of rabies biologicals in pediatric patients following Category III anima...
Saved in:
Main Authors: | Fotedar Nidhi (Author), Ravish HS (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and clinical efficacy of human rabies immunoglobulin in post exposure prophylaxis for category III animal exposures
by: Ravish S. Haradanhalli, et al.
Published: (2022) -
Defining the volume of rabies immunoglobulins/ rabies monoclonal antibodies requirement for wound infiltration of category III animal exposures - an exploratory study
by: Ravish S. Haradanhalli, et al.
Published: (2021) -
IJCM_365A: A prospective study on the safety and clinical efficacy of rabies monoclonal antibodies for post exposure prophylaxis in suspected animal exposures at the anti rabies clinic of KIMS Hospital and Research Centre, Bangalore
by: Poornima M K, et al.
Published: (2024) -
Active safety surveillance of rabies monoclonal antibody and rabies vaccine in patients with category III potential rabies exposureResearch in context
by: Gagandeep Kang, et al.
Published: (2023) -
Compliance to anti-rabies vaccination in post-exposure prophylaxis
by: Ravish Haradanahalli Shankaraiah, et al.
Published: (2015)